The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study-Reference-Cited by-同舟云学术

The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study

Published:2020-09-03 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Rivera Raquel¹^ORCID,Velasco Manuel²,Vidal David³,Carrascosa J. Manuel⁴,Daudén Esteban⁵,Vilarrasa E⁶,Notario Jaime⁷,Ruíz‐Villaverde Ricardo⁸^ORCID,Yanguas Ignacio⁹,García‐Latasa Francisco Javier¹⁰,Ferrán Marta¹¹,Lázaro‐Simó Anna¹²,Cueva Pablo¹³,Salgado‐Boquete Laura¹⁴,Belinchón Isabel¹⁵

Affiliation:

1. Dermatology Department Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid Madrid Spain

2. Dermatology Department Hospital Arnau de Vilanova Valencia Spain

3. Dermatology Department Hospital Sant Joan Despi Moises Broggi Barcelona Spain

4. Dermatology Department Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona Barcelona Spain

5. Dermatology Department Hospital Univesitario La Princesa Madrid Spain

6. Dermatology Department Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona Barcelona Spain

7. Dermatology Department Hospital Universitario de Bellvitge. Hospitalet de Llobregat Barcelona Spain

8. Dermatology Department Hospital Universitario San Cecilio Granada Spain

9. Dermatology Department Complejo Hospitalario de Navarra Pamplona Spain

10. Dermatology Department Hospital Royo Villanova Zaragoza Spain

11. Dermatology Department Hospital del Mar, Parc de Salut Mar Barcelona Spain

12. Dermatology Department Hospital Universitario Sagrat Cor Barcelona Spain

13. Dermatology Department Hospital Universitario Infanta Leonor Madrid Spain

14. Dermatology Department Complejo Hospitalario Universitario de Pontevedra Pontevedra Spain

15. Dermatology Department Hospital General Universitario de Alicante Alicante Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14066

Reference14 articles.

1. Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis: epidemiologic study in a real‐world analysis of the French national health insurance database

2. Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy

3. Initial results of ixekizumab efficacy and safety in real‐world plaque psoriasis patients: a multicentre retrospective study

4. Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists biologics and Immunomodulators register, BADBIR);Mahil SK;Br J Dermatol,2019

5. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis;Expert Opinion on Drug Safety;2024-08-17

2. Advantages of IL-17 inhibitor, ixekizumab, in the treatment of severe psoriasis;Meditsinskiy sovet = Medical Council;2024-03-08

3. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium;Immunotherapy;2023-10

4. Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021;Journal of Dermatological Treatment;2023-01-20

5. Ixekizumab treatment in patients with moderate‐to‐severe plaque psoriasis in a real‐world clinical setting;Journal of Cosmetic Dermatology;2022-07-18